A joint formula for a leading sports nutrition brand
Delivered in 2023, alongside further products we scoped for the brand.
At a glance
- TGA-listed medicine
- Formula, evidence, listing and manufacture
The brand
One of Australia's largest direct-to-consumer supplement makers, with more than 100 staff and around 50,000 orders a month (2025).
The challenge
Bring a joint-support formula into its range as a TGA-listed medicine.
What we built
The formula, the claims evidence, the TGA listing, production, and a later listing update to keep it current.
Manufacturing and delivery
We managed manufacturing and interstate freight through to the brand's warehouse.
The result
- Delivered in 2023, alongside further products we scoped for the brand.
Related case studies
Related case studies
Nine products and a long partnership
Five production batches from 2021 to 2025
Read the story →
Rebuilding a sports brand's core range
Five products in production from late 2023
Read the story →The regulatory partner behind an international skincare brand
A regulatory partnership now in its third year.
Read the story →Fifteen minutes on your pipeline. No deck, no obligation.
